Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Improve Cancer-related Cognitive Impairment

University of Alabama at Birmingham · NCT05864274

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–90 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
64
US sites recruiting
1
Study start
September 1, 2024
Record last updated
November 24, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.

Being studied: Cognitive training application

Conditions: Gynecologic Cancer; Chemotherapy Effect; Chemo-brain; Cancer-related Cognitive Difficulties

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion criteria are

  • newly diagnosed gynecologic malignancy (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
  • own a smartphone or tablet with ability to download cognitive training application
  • and age >21 years old

Exclusion criteria include

  • medical diagnosis of dementia
  • significant underlying mental diagnoses for which they are on more than 1 medication for (patients with depression or anxiety on single-agent therapy will be able to participate
  • age \<21

Recruiting US locations

  • University of Alabama at Birmingham

    Birmingham, AL 35233

    Site contact: Teresa KL Boitano, MD · 205-934-0462 · tlboitano@uabmc.edu

Study contacts (from the official record)

  • Teresa K Boitano, MD · 2059344986 · tlboitano@uabmc.edu
  • Rebecca Arend, MD · rarend@uabmc.edu
All neurology studies in Alabama →
Improve Cancer-related Cognitive Impairment (NCT05864274) | Bored Studies